Segmentation of the Antibodies Market Segment is primarily analyzed by product type and application (therapy area).

• By Product Type: Monoclonal Antibodies (mAbs) dominate the market, holding the largest revenue share (often over 64% of the market) due to their high specificity and widespread application in various diseases. The Bispecific Antibodies segment is projected to witness the fastest growth rate, driven by their dual-targeting properties and enhanced therapeutic advantages in oncology.

• By Application: The Oncology/Cancer segment holds the largest market share (around 48% to 53%) driven by the high prevalence of cancer and the success of targeted immuno-oncology therapies. However, the Autoimmune Diseases and Inflammatory Disorders segment is consistently projected to be the fastest-growing application area due to the large number of existing marketed antibody therapeutics and a strong pipeline of new drugs. [Antibodies Market Segment]